No Detail Found!

Iloprost Instillation in Two Neonates with Pulmonary Hypertension.

Author(s)
Sezin Unal Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey; Department of Neonatology, Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital, Ankara, Turkey
Selma Aktas Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey
Meltem Aksu Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey
Ibrahim M Hirfanoglu Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey
Yildiz Atalay Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey
Canan Turkyilmaz Department of Pediatrics, Division of Neonatology, Gazi University Hospital, Ankara, Turkey
Abstract
Pulmonary hypertension may coexist with certain diseases in neonates. Iloprost inhalation is one of the treatments which cause selective pulmonary vasodilatation. Inhalation is not an easy way of drug administration in mechanically ventilated infants; as some exhibit desaturations during inhalation. Moreover, inhalation of drug requires cessation of mechanical ventilation, if patient is on high frequency oscillatory ventilation. We presented two patients with pulmonary hypertension; term baby with congenital diaphragmatic hernia and preterm baby with respiratory distress syndrome; who had iloprost instillation during mechanical ventilation treatment. Iloprost instillation was well tolerated with no side effects in the term patient with diaphragmatic hernia; whereas severe blood pressure fluctuations were observed in the preterm infant. This report may courage administration of iloprost in term neonates with resistant pulmonary hypertension.
Publication Details
Page(s) 257-259
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 4, Year: 2017

Request the full text from PASTIC

References
American, 2000.Use of inhaled nitric oxide,Pediatrics 106 344 -5
De LucaD,ZeccaE,PiastraM,RomagnoliC, 2007.Iloprost as 'rescue' therapy for pulmonary hypertension of the neonate,Paediatr Anaesth 17 394 -5
EhlenM,WiebeB., 2003.Iloprost in persistent pulmonary hypertension of the newborn,Cardiol Young 13 361 -3
De JaegereAP, 1998.Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension,Eur Respir J 12 932 -4
KinsellaJP,SteinhornRH,KrishnanUS,FeinsteinJA,AdatiaI,AustinED, 2016.Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension,J Pediatr 170 312 -4
MubarakKK, 2010.A review of prostoglandin analogues in the management of patients with pulmonary arterial hypertension,Respir Med 104 9 -21
ShivanandaS,AhliwahliaL,KluckowM,LucJ,JankovR,McNamaraP, 2012.Variation in the management of persistent pulmonary hypertension of the newborn: A survey of physicians in Canada, Australia, and New Zealand,Am J Perinatol 29 519 -26
PiastraM,De LucaD,De CarolisMP,TemperaA,StivalE,CaliandroF, 2012.Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: A case series,Pediatr Pulmonol 47 757 -62
OlschewskiH,GhofraniHA,WalmrathD,SchermulyR,Temmesfeld-WollbrückB,GrimmingerF, 2000.Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis,Pneumologie 54 133 -42
PerlmanJM,McMenaminJB,VolpeJJ, 1983.Fluctuating cerebral blood-flow velocity in respiratory-distress syndrome. Relation to the development of intraventricular hemorrhage,N Engl J Med 309 204 -9
0

Citations

0

Downloads

56

Views